Frost Radar™: US Population Health Management, 2026
A Benchmarking System to Spark Companies to Action - Innovation That Fuels New Deal Flow and Growth Pipelines
10-Jul-2026
North America
Frost Radar
PLWW-01-00-00-00
HC_2026_34720
The population health management (PHM) market continues to benefit from provider participation in risk-based reimbursement models, including Medicare Advantage, the Medicare Shared Savings Program, and other value-based care arrangements. As organizations assume greater financial accountability, demand is increasing for platforms that can improve quality performance, optimize resource utilization, and support population-level risk management. Healthcare organizations are prioritizing solutions that translate insights into action. While analytics and risk stratification remain foundational, buyers are seeking platforms that embed care coordination, patient engagement, quality management, and performance improvement directly into clinical and operational workflows. This shift is accelerating demand for workflow-centric PHM platforms that support measurable outcomes rather than reporting alone. The availability of clinical, claims, pharmacy, and social determinants data is increasing the need for unified population health strategies. Organizations are seeking platforms that can activate disparate data sources to support longitudinal patient visibility, risk adjustment, attribution management, and financial performance improvement. Vendors that effectively connect and operationalize data across payer and provider ecosystems are strengthening their competitive position. AI adoption in PHM is expanding beyond predictive analytics into workflow automation, intervention prioritization, diagnosis gap identification, and care orchestration. Market demand is increasingly focused on practical, explainable, and workflow-integrated AI capabilities that improve productivity and support proactive population management while maintaining clinician oversight.
Frost & Sullivan analyzes numerous companies in an industry. Those selected for further analysis based on their leadership or other distinctions are benchmarked across 10 Growth and Innovation criteria to reveal their position on the Frost Radar™. The publication presents competitive profiles of each company on the Frost Radar™ considering their strengths and the opportunities that best fit those strengths.
Author: Sagar Thamaji Mukhekar
Arcadia
Athenahealth
Azara Healthcare
Cedar Gate Technologies
eClinicalWorks
Epic Systems
Evolent Health
Health Catalyst
HealthEdge Software
Innovaccer
Lightbeam Health Solutions
Medecision
NextGen Healthcare
Optum
Oracle Health
ZeOmega
Significance of Being on the Frost Radar™
CEO's Growth Team
Investors
Customers
Board of Directors
Frost Radar™: Benchmarking Future Growth Potential 2 Major Indices, 10 Analytical Ingredients, 1 Platform
Growth Index
Growth Index (GI) is a measure of a company’s growth performance and track record, along with its ability to develop and execute a fully aligned growth strategy and vision; a robust growth pipeline system; and effective market, competitor, and end-user focused sales and marketing strategies.
-
Market Share (previous 3 years)
This is a comparison of a company’s market share relative to its competitors in a given market space for the previous 3 years. -
Revenue Growth (previous 3 years)
This is a look at a company’s revenue growth rate for the previous 3 years in the market/industry/category that forms the context for the given Frost Radar™. -
Growth Pipeline
This is an evaluation of the strength and leverage of a company’s growth pipeline system to continuously capture, analyze, and prioritize its universe of growth opportunities. -
Vision and Strategy
This is an assessment of how well a company’s growth strategy is aligned with its vision. Are the investments that a company is making in new products and markets consistent with the stated vision? -
Sales and Marketing
This is a measure of the effectiveness of a company’s sales and marketing efforts in helping it drive demand and achieve its growth objectives.
Innovation Index
Innovation Index (II) is a measure of a company’s ability to develop products/ services/ solutions (with a clear understanding of disruptive Mega Trends) that are globally applicable, are able to evolve and expand to serve multiple markets and are aligned to customers’ changing needs.
-
INNOVATION SCALABILITY
This determines whether an organization’s innovations are globally scalable and applicable in both developing and mature markets, and also in adjacent and non-adjacent industry verticals. -
RESEARCH AND DEVELOPMENT
This is a measure of the efficacy of a company’s R&D strategy, as determined by the size of its R&D investment and how it feeds the innovation pipeline. -
PRODUCT PORTFOLIO
This is a measure of a company’s product portfolio, focusing on the relative contribution of new products to its annual revenue. -
MEGATRENDS LEVERAGE
This is an assessment of a company’s proactive leverage of evolving, long-term opportunities and new business models, as the foundation of its innovation pipeline. -
CUSTOMER ALIGNMENT
This evaluates the applicability of a company’s products/services/solutions to current and potential customers, as well as how its innovation strategy is influenced by evolving customer needs.
Significance of Being on the Frost Radar™
Companies plotted on the Frost RadarTM are the leaders in the industry for growth, innovation, or both. They are instrumental in advancing the industry into the future.
-
GROWTH POTENTIAL
Your organization has significant future growth potential, which makes it a Company to Action. -
BEST PRACTICES
Your organization is well positioned to shape Growth Pipeline™ best practices in your industry. -
COMPETITIVE INTENSITY
Your organization is one of the key drivers of competitive intensity in the growth environment. -
CUSTOMER VALUE
Your organization has demonstrated the ability to significantly enhance its customer value proposition. -
PARTNER POTENTIAL
Your organization is top of mind for customers, investors, value chain partners, and future talent as a significant value provider.
Speak directly with our analytics experts for tailored recommendations.
Recent related Digital Health research
24 Aug 2026 | Global | Market Research
Growth Opportunities in Real-Time Location Systems in the Healthcare Industry, Forecast to 2031
The global healthcare RTLS market is evolving beyond traditional asset tracking toward intelligent location platforms that enable real-time visibility, workflow optimization, and operational decision-making across healthcare environments. As healthcare providers continue investing in digital transfo...
21 Aug 2026 | Global | Technology Research
Innovations and Growth Opportunities in AI-Driven Biomanufacturing, Advanced Cell and Gene Therapies, and Precision Immunotherapy
This edition of the Life Science, Health & Wellness Technology Opportunity Engine (TOE) provides a comprehensive overview of breakthrough innovations reshaping biomanufacturing, cell and gene therapy, precision immunotherapy, anti-infectives, and neurotherapeutics across oncology, infectious disease...
11 Aug 2026 | Global | Market Research
Growth Opportunities in the Healthcare Cloud Market, Global, Forecast to 2031
The global healthcare cloud market is expanding as healthcare organizations move beyond early cloud adoption and begin to use cloud environments as a foundation for managing data, enabling interoperability, and supporting more integrated clinical and operational workflows. As adoption matures, cloud...
06 Aug 2026 | Global | Technology Research
Decentralized Clinical Trials Powered by Blockchain and Digital Twins
This report examines how decentralized clinical trials (DCTs), enabled by blockchain, digital twins, and artificial intelligence, are reshaping global clinical research. It traces the shift from site-centric to patient-centric models and quantifies the growing scale, globalization, and complexity of...
05 Aug 2026 | Global | Technology Research
Neuroregeneration: From Predictive Biomarkers to Brain Repair
The report describes how predictive biomarkers are changing the global landscape of neuroregeneration and transitioning from the concept of control of brain injury to an active repair of the brain. This report describes how brain injuries from scans were being replaced by blood tests being developed...
Purchase includes:
- Report download
- Growth Dialog™ with our experts
Growth Dialog™
A tailored session with you where we identify the:- Strategic Imperatives
- Growth Opportunities
- Best Practices
- Companies to Action
Impacting your company's future growth potential.
Frost & Sullivan analyzes numerous companies in an industry. Those selected for further analysis based on their leadership or other distinctions are benchmarked across 10 Growth and Innovation criteria to reveal their position on the Frost Radar™. The publication presents competitive profiles of each company on the Frost Radar™ considering their strengths and the opportunities that best fit those strengths.
Author: Sagar Thamaji Mukhekar
| Deliverable Type | Frost Radar |
|---|---|
| Industries | Healthcare |
| No Index | No |
| Is Prebook | No |
| Keyword 1 | Population Health Management Market Report |
| Keyword 2 | US Population Health Management Analysis |
| Keyword 3 | PHM Market Report |
| Podcast | No |
| Predecessor | KA94-01-00-00-00 |
| WIP Number | PLWW-01-00-00-00 |